Alyeska Investment Group, L.P. Regulus Therapeutics Inc. Transaction History
Alyeska Investment Group, L.P.
- $25 Billion
- Q4 2024
A detailed history of Alyeska Investment Group, L.P. transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 1,037,500 shares of RGLS stock, worth $1.33 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,037,500
Previous 1,037,500
-0.0%
Holding current value
$1.33 Million
Previous $1.63 Million
0.68%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding RGLS
# of Institutions
70Shares Held
53.5MCall Options Held
13.7KPut Options Held
7K-
Federated Hermes, Inc. Pittsburgh, PA12.9MShares$16.5 Million0.05% of portfolio
-
Nea Management Company, LLC Timonium, MD6.47MShares$8.28 Million0.73% of portfolio
-
Vivo Capital, LLC Palo Alto, CA5MShares$6.4 Million1.54% of portfolio
-
Octagon Capital Advisors LP New York, NY4.85MShares$6.21 Million1.71% of portfolio
-
Black Rock Inc. New York, NY3.97MShares$5.08 Million0.0% of portfolio
About Regulus Therapeutics Inc.
- Ticker RGLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,634,400
- Market Cap $18.7M
- Description
- Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...